메뉴 건너뛰기




Volumn 22, Issue 11, 2001, Pages 926-933

Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease

Author keywords

Arterial hypertension; Coronary risk factors; Epidemiology; Myocardial infarction; Positive family history; Primary prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 0034929980     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2413     Document Type: Article
Times cited : (27)

References (30)
  • 1
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
    • The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 2
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
    • Cholesterol and Recurrent Events Trial investigators
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3
  • 3
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4s)
    • (1994) Lancet , vol.344 , Issue.8934 , pp. 1383-1389
  • 4
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
    • West of Scotland Coronary Prevention Study Group
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3
  • 6
    • 0025347391 scopus 로고
    • Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
    • (1990) Lancet , vol.335 , Issue.8693 , pp. 827-838
    • Collins, R.1    Peto, R.2    MacMahon, S.3
  • 7
    • 0029960897 scopus 로고    scopus 로고
    • Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials
    • (1996) J Am Coll Cardiol , vol.27 , pp. 1214-1218
    • Moser, M.1    Hebert, P.R.2
  • 8
    • 0030892604 scopus 로고    scopus 로고
    • Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction
    • American Heart Association Science Advisory and Coordinating Committee
    • (1997) Circulation , vol.95 , pp. 2329-2331
    • Grundy, S.M.1    Balady, G.J.2    Criqui, M.H.3
  • 12
    • 0032189666 scopus 로고    scopus 로고
    • Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention
    • (1998) Eur Heart J , vol.19 , pp. 1434-1503
    • Wood, D.1
  • 18
    • 0023866516 scopus 로고
    • The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): A major international collaboration
    • WHO MONICA Project Principal Investigators
    • (1988) J Clin Epidemiol , vol.41 , pp. 105-114
  • 24
    • 0024204295 scopus 로고
    • Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years
    • (1988) Wld Hlth Statist Quart , vol.41 , pp. 115-120
  • 27
    • 85044706316 scopus 로고    scopus 로고
    • A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results
    • EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events
    • (1997) Eur Heart J , vol.18 , pp. 1569-1582
  • 30
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • HOT Study Group
    • (1998) Lancet , vol.351 , Issue.9118 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.